Clinical Trial: Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers
Sponsor and Collaborators
IO-Studien-gGmbH
Contact
Contact: Anne L. Kranich, Dr.
+ 49 40 44 19 54 60
[email protected]
Principal Investigator
Karin Jordan, Dr. med. Universitätslinikum der Martin-Luther Universität Halle-Wittenberg
ClinicalTrials.gov Identifier
NCT01200121
Please login or register first to view this content.
Enjoying our content?
Thanks for visiting Oncology Nurse Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Oncology Nurse Advisor. Register for free and gain unlimited access to:
- Clinical Updates
- Evidence-Based Guidance
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Please login or register first to view this content.